We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

151 hedge funds and large institutions have $578M invested in Array Biopharma Inc in 2015 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 45

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less funds holding

Funds holding: 157 → 151 (-6)

11% less capital invested

Capital invested by funds: $653M → $578M (-$75M)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

44% less call options, than puts

Call options by funds: $6.85M | Put options by funds: $12.2M

Holders
151
Holders Change
-6
Holders Change %
-3.82%
% of All Funds
3.96%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
48
Reduced
45
Closed
28
Calls
$6.85M
Puts
$12.2M
Net Calls
-$5.33M
Net Calls Change
-$7.65M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$11.1M
2
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M
3
VAM
Visium Asset Management
New York
+$9.08M
4
OAM
Oxford Asset Management
United Kingdom
+$4.86M
5
TA
Teachers Advisors
New York
+$4.77M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$23.5M
2
TCM
TimesSquare Capital Management
New York
-$16.6M
3
BI
BVF Inc
California
-$13.7M
4
Invesco
Invesco
Georgia
-$10.5M
5
State Street
State Street
Massachusetts
-$7.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
76
Group One Trading
Illinois
$450K +$487K +106,714 New
UBS AM
77
UBS AM
Illinois
$436K +$27.4K +6,000 +6%
TAM
78
Tocqueville Asset Management
New York
$423K +$45.6K +10,000 +11%
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
$410K – – –
NFA
80
Nationwide Fund Advisors
Ohio
$390K +$4.49K +984 +1%
Squarepoint
81
Squarepoint
New York
$390K +$422K +92,500 New
State Board of Administration of Florida Retirement System
82
State Board of Administration of Florida Retirement System
Florida
$359K – – –
AIG
83
American International Group
New York
$354K -$1.56K -343 -0.4%
VFA
84
Virtus Fund Advisers
Connecticut
$344K -$3.92K -858 -1%
DekaBank Deutsche Girozentrale
85
DekaBank Deutsche Girozentrale
Germany
$300K +$6.85K +1,500 +2%
BG
86
BlackRock Group
United Kingdom
$296K +$161K +35,339 +102%
PPA
87
Parametric Portfolio Associates
Washington
$289K +$98.2K +21,519 +46%
LCM
88
Landscape Capital Management
New Jersey
$271K +$293K +64,236 New
VOYA Investment Management
89
VOYA Investment Management
Georgia
$266K – – –
Barclays
90
Barclays
United Kingdom
$265K -$349K -76,401 -54%
Bank of America
91
Bank of America
North Carolina
$261K -$78.4K -17,171 -22%
SCA
92
Secor Capital Advisors
New York
$254K +$275K +60,305 New
NSEDCP
93
NJ State Employees Deferred Compensation Plan
New Jersey
$253K – – –
AQR Capital Management
94
AQR Capital Management
Connecticut
$240K -$227K -49,817 -47%
Balyasny Asset Management
95
Balyasny Asset Management
Illinois
$204K -$101K -22,090 -31%
NIT
96
NumerixS Investment Technologies
British Columbia, Canada
$202K +$76.7K +16,800 +54%
SCM
97
Stevens Capital Management
Pennsylvania
$169K -$444K -97,271 -71%
ICOA
98
Investment Centers of America
North Dakota
$158K – – –
GCP
99
GSA Capital Partners
United Kingdom
$153K -$588K -128,748 -78%
Royal Bank of Canada
100
Royal Bank of Canada
Ontario, Canada
$151K -$56.3K -12,340 -26%
2 3
4
5 6

ARRY Hedge Fund Activity: Q4 2015 in Review

151 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q4 2015, worth a combined $578M — down 11% from $653M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ARRY and 23 opened new positions — a net loss of 5 holders — while 45 trimmed existing stakes and 48 added.

The largest buyer was Millennium Management, adding an estimated $11.1M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $23.5M sold.

  • 151 institutional investors held Array Biopharma Inc (ARRY) as of Q4 2015, down from 157 in Q3 2015.
  • Funds reported $578M of Array Biopharma Inc stock for Q4 2015, down 11% quarter-over-quarter.
  • 23 funds opened new Array Biopharma Inc positions in Q4 2015 and 28 closed out, a net change of -5 holders.
  • The largest Array Biopharma Inc buyer in Q4 2015 was Millennium Management, an estimated $11.1M added.
  • The largest Array Biopharma Inc seller in Q4 2015 was T. Rowe Price Associates, an estimated $23.5M sold.

Based on aggregated 13F filings for Q4 2015.